期刊
JOURNAL OF SURGICAL ONCOLOGY
卷 102, 期 8, 页码 937-945出版社
WILEY
DOI: 10.1002/jso.21760
关键词
metastatic colorectal cancer; liver metastases; peri-operative treatment; biological targeted treatment
In the treatment of metastatic colorectal cancer, the subset of patients with liver-only metastases shows the greatest promise for prolonged survival and cure. Advances in surgery and medical treatment have encouraged multimodality treatment strategies and therefore require a true multidisciplinary approach. The current standard of care includes peri-operative chemotherapy and surgery. The new era of biologically targeted therapy requires an in-depth look at the possible efficacy and risks of adding these agents to the treatment protocol. J. Surg. Oncol. 2010; 102: 937-945. (C) 2010 Wiley-Liss, Inc.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据